Emerald Cloud Lab

Primary contact

Formerly known as Emerald Therapeutics, Emerald Cloud Lab (ECL) is a scientist-led company re-imagining the way laboratory research is conducted. The company's system was designed to sweep aside the daily grind scientists face in the laboratory and allows the day-to-day work to center on orchestrating science. It is a state-of-the-art life sciences laboratory that scientists can remotely access via the Internet where automated robotics conduct experiments exactly as specified by the user. Scientists using the ECL log onto a website and specify all of the parameters for a given experiment as if they were standing in front of the instrument. The experiment is then executed using Emerald's robotically automated systems, and all of the data generated is automatically cataloged and placed into a database where it is accessible to the user. The system also provides powerful tools to plot, analyze, and share data with other scientists. This platform is meant to expand the scope of experiments that scientists currently run in their own labs by providing instant access via the Internet to a comprehensive set of validated experimental protocols and instrumentation without the high upfront costs of both time and money. The ECL also provides more robust and reproducible data: because all experimental and environmental variables are captured by the system, it is possible to robotically replicate experiments with the push of a button. Finally, the ECL offers a persistent database accessible over the Internet where investigators can instantaneously browse or query past experiments and data with extreme precision. Emerald hopes that the ECL will provide scientists will a larger experimental toolbox, allow for more reproducible results and shared knowledge between scientists and labs, and dramatically reduce the overhead required to begin new research programs and biotechnology companies. The ECL currently supports over 40 standard types of life science experiments, from Western Blots to MALDI Mass Spectrometry, with the intention of supporting over 100 standard experiment types within 18 months.
Primary contact

Funding 💰

Total $34M
Select investors Founders Fund, Max Levchin, Schooner Capital, Sound Ventures, OS Fund, Faridan, Western Technology Investment
Last update: May 23, 2018